Popular Super Greens Supplement Recalled After Salmonella Illnesses Reported

By I. Edwards HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 16, 2026.

FRIDAY, Jan. 16, 2026 — A powdered super greens supplement sold across the U.S. has been recalled after federal health officials linked it to a Salmonella outbreak that has sickened people in at least 21 states.

At least 45 people have become ill after consuming Live it Up-brand Super Greens powder, according to U.S. Food and Drug Administration (FDA) and the U.S. Centers for Disease Control and Prevention (CDC).

At least, 12 people have been hospitalized. No deaths have been reported.

The product’s manufacturer, Superfoods Inc., issued a nationwide recall Wednesday of its Super Greens powder, including original and wild berry flavors, with expiration dates ranging from August 2026 through January 2028.

Health officials say illnesses linked to the supplement began between Aug. 22 and Dec. 30, 2025.

The powder was sold nationwide, and, according to the Associated Press, cases of Salmonella have been reported in Alabama, Connecticut, Delaware, Iowa, Illinois, Kentucky, Massachusetts, Maine, Michigan, Minnesota, Missouri, Nebraska, New York, Ohio, Pennsylvania, South Carolina, Tennessee, Utah, Vermont, Washington and Wisconsin.

A federal investigation is still underway, and agency officals warn that additional products may be affected as it continues.

Consumers are advised not to eat, sell or serve the recalled powder and to either throw it away or return it to place of purchase.

Salmonella can cause diarrhea, stomach cramps, fever, vomiting and dehydration. Most people recover without treatment, but some may need hospitalization.

Sources

The Associated Press, Jan. 14, 2026
U.S. Food and Drug Administration, Jan. 14, 2026

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.